Find a Tender
complete
Official procurement procedure
e-PCR Machines and Reagents
Biochemical analysers
Biomedical equipment
Laboratory reagents
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Department of Health and Social Care: "e-PCR Machines and Reagents". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | Department of Health and Social Care | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: Department of Health and Social Care
Market Analytics
Derived from OCDS awards & bid statistics
Published history for Department of Health and Social Care. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
11.8Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 451 active published awards; 397 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityDepartment of Health and Social Care | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published20 Jan 2021, 16:00 GMT | Last source update20 Jan 2021, 16:00 GMT | Recurring procurementNot published |
ClassificationBiochemical analysers, Biomedical equipment, Laboratory reagents | ||
Delivery area UK | ||
OCIDocds-h6vhtk-028bf1 | ||
What is being bought
Nexar platforms and associated consumables to determine the presence or absence of SARS CoV-2 via End Point-PCR from saliva samples. Includes maintenance, support and training associated with the Goods.
What changed
From the official release history
- Status changed to complete
20 Jan 2021, 16:00 GMT - Official notice release published
20 Jan 2021, 16:00 GMT - Buyer information updated
20 Jan 2021, 16:00 GMT
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcancelledPublished valueNot publishedNexar platforms and associated consumables to determine the presence or absence of SARS CoV-2 via End Point-PCR from saliva samples. Includes maintenance, support and training associated with the Goods.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
20 Jan 2021, 16:00 GMT - Award active
Not published · Not published - Contract active
Signed 22 Dec 2020, 00:00 GMT · £117,928,510
Commercial outcome and competition
Awards LGC Genomics Ltd Not published · Not published · active |
Contracts Contract £117,928,510 · signed 22 Dec 2020, 00:00 GMT · active |
Bid statistics bids: 1 (lot 1) |
Buyer and organisations in this procedure
Department of Health and Social Care
Contracting authority GB-FTS-43Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleFollowing an earlier contract award to LGC on 23 August 2020 for an initial purchase of Nexar platforms, the machines have now successfully passed the required testing and validations.Since the August contract award, there is a requirement for further Nexar platforms (and associated consumables) to be deployed into Mega Labs that are being established to meet national COVID-19 testing targets. DHSC considers that the required deliverables can be supplied only by LGC because the competition is absent for technical reasons, no reasonable alternative or substitute exists and the absence of competition is not the result of an artificial narrowing down of the parameters of the procurement.In particular, DHSC considers that there are no other suppliers in the market who are able to offer equipment (which is only available as part of a package including associated consumables) with the potential to achieve the ultra-high levels of testing offered by LGC's Nexar instruments.DHSC has therefore proceeded with the award of the contract to LGC for the supply further Nexar machines and associated consumables using the negotiated procedure without prior publication, pursuant to Regulation 32(2)(b)(ii) of the Public Contracts Regulations 2015 for the purpose of enabling a step-change in COVID-19 testing capacity at the UK Biocentre in Milton Keynes and the upcoming Mega Labs. Within the contract there is an option for additional Nexar platforms, and optional consumables to be called-off as required by DHSC. |